| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $699.0M | +39.6% |
| Cost of Revenue | $206.3M | +44.2% |
| Gross Profit | $492.6M | +37.8% |
| R&D Expense | $171.0M | +42.9% |
| SG&A Expense | $140.1M | +47.1% |
| Operating Income | -$116.9M | -88.7% |
| Interest Expense | $2.3M | — |
| Pre-tax Income | -$132.3M | -130.1% |
| Income Tax | $3.3M | +139.8% |
| Net Income | -$135.6M | -175.7% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.51B | +124.8% |
| Accounts Receivable | $114.2M | +50.6% |
| Current Assets | $1.78B | +113.2% |
| Total Assets | $2.70B | +68.4% |
| Current Liabilities | $567.7M | +49.8% |
| Total Liabilities | $1.67B | +220.2% |
| Stockholders' Equity | $1.03B | -5.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $34.1M | -19.9% |
| Capital Expenditures | $7.7M | +70.2% |
| Investing Cash Flow | -$100.3M | +73.5% |
| Financing Cash Flow | $918.9M | +51.6% |
| Free Cash Flow | $26.5M | -30.6% |